SZSE Ticker: 000518

Jiangsu Sihuan Bioengineering Co., Ltd

江苏四环生物股份有限公司

四环生物

JSSH

Listing Date: 1993-09-08

Board: Main Board - A Shares

Industry Classification: Manufacturing

my country's financial data is freshly released, it can be said to be lackluster

Post date May 15, 2022 — 11:10 Post Lock

A shares: Six sweaty and bloody BMWs with strong explosiveness next week, it is recommended to collect and study! Current Price_NetEase Subscription

Post date May 15, 2022 — 02:58 Post Lock

772 million book funds to leverage 20 billion investment? Jiangsu Sunshine cross-border photovoltaic is still in doubt

Post date May 12, 2022 — 16:26 Post Lock

The "14th Five-Year Plan" top-level plan for bio-economic development has been released! These sectors have risen sharply, and a trillion-level new track is expected to open

Post date May 10, 2022 — 16:35 Post Lock

The pharmaceutical and biological industry has a net outflow of 1.464 billion yuan today, and 7 shares have a net outflow of more than 100 million yuan.

Post date May 9, 2022 — 18:53 Post Lock

The concept of hepatitis fluctuates and strengthens, and the General Administration of Customs strictly prevents the introduction of acute severe hepatitis in children of unknown cause.

Post date May 9, 2022 — 12:13 Post Lock

The concept of hepatitis fluctuates and strengthens, and the General Administration of Customs strictly prevents the introduction of acute severe hepatitis in children of unknown cause-CFi.CN Zhongcai Network

Post date May 9, 2022 — 12:11 Post Lock

The concept of hepatitis fluctuates and strengthens, and the General Administration of Customs is strictly preventing the introduction of acute severe hepatitis in children of unknown cause – yqqlm

Post date May 9, 2022 — 12:11 Post Lock

With a shot of 20 billion, will the textile leader Jiangsu Sunshine succeed in fighting photovoltaics again? Jiangsu Sunshine_Sina Finance_Sina.com

Post date April 22, 2022 — 22:23 Post Lock

Daily Market Hotspot Analysis

Post date April 19, 2022 — 11:12 Post Lock

China Biotech's two new coronavirus Omicron inactivated vaccines received clinical approval from Hong Kong Junshi Bio's new crown oral drug VV116 released the latest research results

Post date April 18, 2022 — 18:46 Post Lock

Watching the market: Maoye Commercial and other 2 stocks stopped in seconds CFi.CN Zhongcai Network

Post date April 18, 2022 — 10:56 Post Lock

Each transaction volume of 85 shares increased by more than 50% _ Oriental Fortune Net

Post date April 14, 2022 — 20:39 Post Lock

The biomedical sector rose 1.09%, and Wanfu Bio rose 14.53% to top the list – yqqlm

Post date April 14, 2022 — 16:55 Post Lock

On April 14, Sihuan Biology saw a substantial inflow of main funds

Post date April 14, 2022 — 16:50 Post Lock